Citrate synthase (CS) is a Krebs tricarboxylic acid cycle enzyme that catalyzes citrate synthesis from oxaloacetate and acetyl coenzyme A. CS inactivation facilitates aerobic glycolysis and cancer progression and targeting citrate can be regarded as a novel therapeutic strategy in cancer treatment (62, 63). Here, CS is linked to cancer.